Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Nocturnal Hypertension in T1DM Adolescents
NCT02644590Phase 1Unknown
- Sponsor
- Sheba Medical Center
- Start
- Feb 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of melatonin in nocturnal hypertension (NH), sponsored by Sheba Medical Center. Primary endpoint: Ambulatory Blood Pressure Monitoring at 4 weeks. Status: unknown.
02
Drugs
melatonin
03
Conditions
nocturnal hypertension (NH)
Beyond the preview
Go deeper on NCT02644590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644590.